Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
2016
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
2019
Gastric cancer
2016 Standout
Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
2012
Hypoxia-Inducible Factor-1-Dependent Repression of E-cadherin in von Hippel-Lindau Tumor Suppressor–Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B
2006 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
2003
Three-Field Lymphadenectomy for Carcinoma of the Esophagus and Gastroesophageal Junction in 174 R0 Resections: Impact on Staging, Disease-Free Survival, and Outcome
2004
Hereditary diffuse gastric cancer: association with lobular breast cancer
2007
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Ulcerative Colitis
2011 Standout
Glut1 expression in T1 and T2 stage colorectal carcinomas
2001
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
2008 Standout
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
2004
Differential Expression of the Epithelial-Mesenchymal Transition Regulators Snail, SIP1, and Twist in Gastric Cancer
2002
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families
2001
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
2010
Imaging in the era of molecular oncology
2008 StandoutNature
Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma
2018
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Crohn's disease
2012 Standout
Epithelial-Mesenchymal Transitions
2004 Standout
Hydrolytic function of Exo1 in mammalian mismatch repair
2014 StandoutNobel
Esophageal Cancer
2003 Standout
Complex networks orchestrate epithelial–mesenchymal transitions
2006 Standout
The molecular biology of head and neck cancer
2010 Standout
Cadherin and catenin alterations in human cancer
2002
Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World
2001
Cancer genes and the pathways they control
2004 Standout
Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements
1999
The Systemic Progression of Human Cancer: A Focus on the Individual Disseminated Cancer Cell—The Unit of Selection
2003
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Ulcerative colitis
2012 Standout
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
DNA copy number profiling in esophageal Barrett adenocarcinoma:
2001
Oesophageal carcinoma
2013 Standout
Persistent p53 Mutations in Single Cells from Normal Human Skin
2001
Hereditary Diffuse Gastric Cancer: Diagnosis and Management
2006
p53 in health and disease
2007 Standout
Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
2011
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Differential Expression of E-Cadherin in Lobular and Ductal Neoplasms of the Breast and Its Biologic and Diagnostic Implications
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
EMT: 2016
2016 Standout
Telomeres, stem cells, senescence, and cancer
2004
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
2008 Standout
Hereditary diffuse gastric cancer
2001
Coupling of Human DNA Excision Repair and the DNA Damage Checkpoint in a Defined in Vitro System
2014 StandoutNobel
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Met, metastasis, motility and more
2003 Standout
Gastric cancer
2020 Standout
The basics of epithelial-mesenchymal transition
2009 Standout
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
2007
E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations
2005
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations
2001
Fibroblasts in cancer
2006 Standout
Plasticity, Nuclear Diapause, and a Requiem for the Terminal Differentiation of Epithelia
2007
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E‐cadherin and catenin expression and microsatellite instability
2003
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
RASSF tumor suppressor gene family: Biological functions and regulation
2014
Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
2001
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
2004 StandoutScience
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
2005
Recommendations for Processing and Reporting of Lymph Node Specimens Submitted for Evaluation of Metastatic Disease
2001
Detection of peritoneal micrometastases of gastric carcinoma with green fluorescent protein and carcinoembryonic antigen promoter.
2001
Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia.
2003
MammalianExo1encodes both structural and catalytic functions that play distinct roles in essential biological processes
2013
Combined GADD45A and Thymidine Phosphorylase Expression Levels Predict Response and Survival of Neoadjuvant-Treated Gastric Cancer Patients
2005
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Molecular Staging of Lymph Nodes from Patients with Esophageal Adenocarcinoma
2005
Denaturing High-Performance Liquid Chromatography Detection of Ribosomal Mutations Conferring Macrolide Resistance in Gram-Positive Cocci
2003
Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein–Barr virus infection and high‐ and low‐microsatellite instability
2019
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Central Adiposity and Risk of Barrett’s Esophagus
2007
Multistep Carcinogenesis: A Chain Reaction of Aneuploidizations
2003
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
2006 Standout
Works of James Mueller being referenced
Denaturing High Pressure Liquid Chromatography (DHPLC) for the Analysis of Somatic p53 Mutations
2001
Diffuse Type Gastric and Lobular Breast Carcinoma in a Familial Gastric Cancer Patient with an E-Cadherin Germline Mutation
1999
Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction
2000
Progressive Changes in Adherens Junction Structure during Intestinal Adenoma Formation in Apc Mutant Mice
2001
The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: A comparative immunohistochemical study
1999
Loss of heterozygosity of the von hippel lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas
1998
Chromosomal Imbalances in Barrett's Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence
2000
EXPRESSION OF bcl-2 AND p53 INDE NOVO AND EX-ADENOMA COLON CARCINOMA: A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY
1996
Loss of Heterozygosity and Microsatellite Instability inDe Novo versus Ex-Adenoma Carcinomas of the Colorectum
1998
Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma
1999
Evaluation of C‐ErbB‐2 Overexpression and Her‐2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
2000
Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction
2000
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
2003
Comprehensive Molecular Analysis of Mismatch Repair Gene Defects in Suspected Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Cases
2009
Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
2003
Barrett’s esophagus: Histopathologic definitions and diagnostic criteria
2004
Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
2000
Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma
1998